MedTrace Logo

Genomic BRCA and Extensive ovArian Cancer Testing

NCT04027868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-02-17

No results posted yet for this study

Summary

This is a prospective observational French multicenter cohort in patients with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014). The objective is to constitute a clinico-biological database that allows to correlate clinical and progressive features of ovarian cancer patients based on tumor genomics and molecular detected abnormalities.

Conditions

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • ARCAGY/ GINECO GROUP

    lead OTHER

Principal Investigators

  • Thibault De La Motte Rouge, MD. · Centre Eugène Marquis, Rennes

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-06
Primary Completion
2022-11-07
Completion
2022-11-07

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027868 on ClinicalTrials.gov